Logo image of AHG

AKSO HEALTH GROUP (AHG) Stock Fundamental Analysis

USA - NASDAQ:AHG - US98422P1084 - ADR

1.68 USD
+0.11 (+7.01%)
Last: 10/7/2025, 3:34:12 PM
Fundamental Rating

3

Overall AHG gets a fundamental rating of 3 out of 10. We evaluated AHG against 101 industry peers in the Health Care Providers & Services industry. AHG has a great financial health rating, but its profitability evaluates not so good. AHG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AHG had negative earnings in the past year.
In the past year AHG had a positive cash flow from operations.
AHG had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AHG reported negative operating cash flow in multiple years.
AHG Yearly Net Income VS EBIT VS OCF VS FCFAHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

AHG has a Return On Assets of -62.79%. This is amonst the worse of the industry: AHG underperforms 95.05% of its industry peers.
AHG has a Return On Equity of -67.79%. This is in the lower half of the industry: AHG underperforms 75.25% of its industry peers.
Industry RankSector Rank
ROA -62.79%
ROE -67.79%
ROIC N/A
ROA(3y)-25.43%
ROA(5y)-42.59%
ROE(3y)-30.24%
ROE(5y)-85.85%
ROIC(3y)N/A
ROIC(5y)N/A
AHG Yearly ROA, ROE, ROICAHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

AHG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHG Yearly Profit, Operating, Gross MarginsAHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

8

2. Health

2.1 Basic Checks

AHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
AHG has a better debt/assets ratio than last year.
AHG Yearly Shares OutstandingAHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
AHG Yearly Total Debt VS Total AssetsAHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 32.40 indicates that AHG is not in any danger for bankruptcy at the moment.
AHG has a Altman-Z score of 32.40. This is amongst the best in the industry. AHG outperforms 99.01% of its industry peers.
The Debt to FCF ratio of AHG is 1.96, which is an excellent value as it means it would take AHG, only 1.96 years of fcf income to pay off all of its debts.
AHG's Debt to FCF ratio of 1.96 is amongst the best of the industry. AHG outperforms 84.16% of its industry peers.
AHG has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AHG (0.01) is better than 84.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.96
Altman-Z 32.4
ROIC/WACCN/A
WACC7.81%
AHG Yearly LT Debt VS Equity VS FCFAHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 14.20 indicates that AHG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 14.20, AHG belongs to the top of the industry, outperforming 99.01% of the companies in the same industry.
A Quick Ratio of 14.18 indicates that AHG has no problem at all paying its short term obligations.
AHG has a better Quick ratio (14.18) than 99.01% of its industry peers.
Industry RankSector Rank
Current Ratio 14.2
Quick Ratio 14.18
AHG Yearly Current Assets VS Current LiabilitesAHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AHG have decreased strongly by -146.56% in the last year.
Looking at the last year, AHG shows a very strong growth in Revenue. The Revenue has grown by 512.09%.
AHG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.45% yearly.
EPS 1Y (TTM)-146.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-374.64%
Revenue 1Y (TTM)512.09%
Revenue growth 3Y35.05%
Revenue growth 5Y16.45%
Sales Q2Q%415.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHG Yearly Revenue VS EstimatesAHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M 80M 100M
AHG Yearly EPS VS EstimatesAHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 1 2 3 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHG Price Earnings VS Forward Price EarningsAHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AHG's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. AHG is more expensive than 60.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 902.18
EV/EBITDA N/A
AHG Per share dataAHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AHG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKSO HEALTH GROUP

NASDAQ:AHG (10/7/2025, 3:34:12 PM)

1.68

+0.11 (+7.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-04 2023-12-04
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap922.66M
AnalystsN/A
Price TargetN/A
Short Float %0.02%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 62.44
P/FCF 902.18
P/OCF 783.77
P/B 4.63
P/tB 5.11
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.11%
OCF(TTM)0
OCFY0.13%
SpS0.03
BVpS0.36
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.79%
ROE -67.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 6.92%
ROA(3y)-25.43%
ROA(5y)-42.59%
ROE(3y)-30.24%
ROE(5y)-85.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.96
Debt/EBITDA N/A
Cap/Depr 7.19%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.2
Quick Ratio 14.18
Altman-Z 32.4
F-Score4
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-374.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)512.09%
Revenue growth 3Y35.05%
Revenue growth 5Y16.45%
Sales Q2Q%415.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.88%
OCF growth 3YN/A
OCF growth 5YN/A